Search

Your search keyword '"van Baren, Nicolas"' showing total 8 results
Start Over Author "van Baren, Nicolas" Publisher wiley
8 results on '"van Baren, Nicolas"'

1. Characterization of the T cell response in allergic contact dermatitis caused by corticosteroids

Author

Baeck, Marie, primary, Soria, Angèle, additional, Marot, Liliane, additional, Theate, Ivan, additional, Hendrickx, Emilie, additional, Van Belle, Astrid, additional, Goossens, An, additional, Tennstedt, Dominique, additional, Dachelet, Claire, additional, Jaeger, Johnathan, additional, Pilette, Charles, additional, Renauld, Jean-Christophe, additional, Van Baren, Nicolas, additional, Rozières, Aurore, additional, Nicolas, Jean-Fançois, additional, and Dumoutier, Laure, additional

Published
2013
Full Text
View/download PDF

6. Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma

Author

Kruit, Wim H.J., primary, van Ojik, Heidi H., additional, Brichard, Vincent G., additional, Escudier, Bernard, additional, Dorval, Thierry, additional, Dréno, Brigitte, additional, Patel, Poulam, additional, van Baren, Nicolas, additional, Avril, Marie-Françoise, additional, Piperno, Sophie, additional, Khammari, Amir, additional, Stas, Marguerite, additional, Ritter, Gerd, additional, Lethé, Bernard, additional, Godelaine, Danièle, additional, Brasseur, Francis, additional, Zhang, Yi, additional, van der Bruggen, Pierre, additional, Boon, Thierry, additional, Eggermont, Alexander M.M., additional, and Marchand, Marie, additional

Published
2005
Full Text
View/download PDF

7. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

Author

Marchand, Marie, primary, van Baren, Nicolas, additional, Weynants, Patrick, additional, Brichard, Vincent, additional, Dr�no, Brigitte, additional, Tessier, Marie-H�l�ne, additional, Rankin, Elaine, additional, Parmiani, Giorgio, additional, Arienti, Flavio, additional, Humblet, Yves, additional, Bourlond, Andr�, additional, Vanwijck, Romain, additional, Li�nard, Danielle, additional, Beauduin, Marc, additional, Dietrich, Pierre-Yves, additional, Russo, Vincenzo, additional, Kerger, Joseph, additional, Masucci, Giuseppe, additional, J�ger, Elke, additional, De Greve, Jacques, additional, Atzpodien, Jens, additional, Brasseur, Francis, additional, Coulie, Pierre G., additional, van der Bruggen, Pierre, additional, and Boon, Thierry, additional

Published
1999
Full Text
View/download PDF

8. A synopsis of serum biomarkers in cutaneous melanoma patients.

Author

Vereecken P, Cornelis F, Van Baren N, Vandersleyen V, and Baurain JF

Abstract

Many serum biomarkers have been evaluated in melanoma but their clinical significance remains a matter of debate. In this paper, a review of the serum biomarkers for melanoma will be detailed and will be discussed from the point of view of their practical usefulness. The expression of biomarkers can be detected intracellularly or on the cell membrane of melanoma cells or noncancer cells in association with the melanoma. Some of these molecules can then be released extracellularly and be found in body fluids such as the serum. Actually, with the emergence of new targeted therapies for cancer and the increasing range of therapeutic options, the challenge for the clinician is to assess the unique risk/response ratio and the prognosis for each patient. New serum biomarkers of melanoma progression and metastatic disease are still awaited in order to provide efficient rationale for followup and treatment choices. LDH as well as S100B levels have been correlated with poor prognosis in AJCC stage III/IV melanoma patients. However, the poor sensitivity and specificity of those markers and many other molecules are serious limitations for their routine use in both early (AJCC stage I and II) and advanced stages of melanoma (AJCC stage III and IV). Microarray technology and proteomic research will surely provide new candidates in the near future allowing more accurate definition of the individual prognosis and prediction of the therapeutic outcome and select patients for early adjuvant strategies.

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results